Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures,
Year: 2011
Type: article
Study design: Observational Study
Source: Blood
Authors: Jason H. Mendler, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Jessica Kohlschmidt, Deedra Nicolet, Heiko Becker, Klaus H. Metzeler, Sebastian Schwind, Susan P. Whitman, William Blum, Bayard L. Powell, Jonathan E. Kolitz, Thomas H. Carter, Meir Wetzler, Joseph O. Moore, Andrew J. Carroll, Maria R. Baer, Richard A. Larson, Michael A Caligiuri, Guido Marcucci, Clara D. Bloomfield
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, Wake Forest University, Northwell Health, University of Iowa, Roswell Park Comprehensive Cancer Center, Duke Medical Center, University of Alabama at Birmingham, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Chicago, The Ohio State University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2979799056